Compare Eli Lilly And Co (LLY) vs Reddit Inc (RDDT) Price & Performance

Eli Lilly (LLY) trades at $1,223.97, down 0.62% on the day, maintaining strong bullish momentum with consecutive earnings beats and robust revenue growth. The stock shows technical strength above key support levels at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 102.44% ROE. Recent quarterly results exceeded expectations, with Q2 2026 revenue surging 48% to $23 billion driven by Mounjaro and Zepbound demand.

Outlook remains positive with analyst consensus targeting $1,380 and 73% buy ratings, though elevated valuations (P/E 40.8) and regulatory risks around weight-loss drug competition present headwinds. The company's pipeline advancement with retatrutide filing expected in 2027 provides medium-term growth catalysts, but investors should monitor execution risks in the competitive obesity drug market.

Reddit (RDDT) trades at $153.46, down 3.3% in the past 24 hours amid bearish technical signals. The company demonstrates strong fundamentals with 61% YoY revenue growth in Q2 2026 and consistent earnings beats, though recent CEO share sales and search traffic concerns have pressured the stock. Technical indicators show resistance at $160 with support at $154, while fundamentals reveal robust profitability with 91.44% gross margins and 31.35% net income margins.

Despite near-term volatility, Reddit's growth trajectory and AI integration opportunities support long-term upside potential. The consensus price target of $220.25 implies 43% upside, though risks include user growth sustainability and competitive pressures. With no sell ratings from 28 covering analysts and strong institutional interest, the stock presents a compelling growth opportunity for patient investors.